Thomas Spiegel

Executive Market Access Leader

Role
Executive Director, Us Oncology Market Access at Bristol Myers Squibb
Location
Princeton, NJ, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Thomas Spiegel

About Strategic and results-driven pharmaceutical executive with over 25 years of experience at Bristol Myers Squibb, specializing in Oncology Market Access, Commercial Strategy, and Global Brand Marketing. Proven track record of leading high-impact product launches, shaping payer strategies, and driving cross-functional initiatives across U.S. and international markets. Passionate about improving patient access and advancing innovative therapies in immuno-oncology. Core Expertise • Oncology Market Access Strategy • Immuno-Oncology Product Launches • Payer & Policy Engagement • Global Commercialization • Value & Pricing Strategy • Cross-Functional Leadership • Sales Force Development • Advanced Payment Models (OCM, EOM, CMMI, Commercial) Career Highlights Executive Director, Oncology US Market Access – Led strategy for expanded oncology portfolio including launch of Opdivo Qvantig and new tumor indications. Influenced clinical development and filing strategies to optimize patient access. Senior Director, Immuno-Oncology Franchise – Directed market access for OPDUALAG, OPDIVO, and YERVOY across multiple tumor types. Spearheaded pricing and access plans for pipeline assets and chaired steering team for OCM 2.0. Global Oncology Commercialization Lead – Oversaw launches and commercialization planning for Yervoy and Nivolumab across diverse international markets. Sales Leadership – ELIQUIS – Elevated district performance from bottom quartile to top third nationally. Piloted innovative access solutions and led regional training initiatives. Education • Executive Education, Marketing – Columbia University • MBA, Finance – Rutgers University • BS, Finance – Lehigh University

Experience

  1. Executive Director, Us Oncology Market Access

    Bristol Myers Squibb

    Nov 2023 — Present

    Leading market access strategy for a $10 Billion Oncology franchise, shaping new product development, executing multiple product launches and delivering market access for thousand of patients in need of advanced and innovative oncology treatments

Education

  • Lehigh University

    bachelor of Science in (B.Sc.) Finance

    1987 — 1991

  • Rutgers Business School

    Master of Business Administration - MBA

    1991 — 1993

  • Lehigh University

    Bachelor of Science

    1987 — 1991

Skills

  • Dermatology
  • Neurology
  • Managed Care
  • Rheumatology
  • Oncology
  • Sales Effectiveness
  • Kidney Transplant
  • Therapeutic Areas
  • Pharmaceutical Industry
  • Cardiology
  • Clinical Trials
  • Diabetes
  • Market Access
  • Pharmaceutical Sales
  • Healthcare
  • Product Launch
  • Endocrinology
  • Strategy
  • Marketing
  • Cross-Functional Team Leadership
  • Global Marketing
  • Biotechnology
  • Strategic Planning

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Thomas Spiegel — Executive Director, Us Oncology Market Access at Bristol Myers Squibb in Princeton, NJ, US | Unifers